Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 11/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | VCP | P55072 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.37 |
| ▸ | PNP | P00491 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | CASP7 | P55210 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9057761 | 0.92 | HPRT1 (0.59) | HPRT1MEN1ALDH1A1LMNACYP3A4 | |
| SCHEMBL7132437 | 0.89 | HPRT1 (0.60) | HPRT1MEN1ALDH1A1LMNACYP3A4 | |
| SCHEMBL8149575 | 0.86 | HPRT1 (0.60) | HPRT1MEN1ALDH1A1LMNACYP3A4 | |
| SCHEMBL2775722 | 0.85 | HPRT1 (0.55) | HPRT1MEN1ALDH1A1LMNACYP3A4 | |
| SCHEMBL10643032 | 0.85 | HPRT1 (0.56) | HPRT1MEN1ALDH1A1LMNACYP3A4 | |
| SCHEMBL336072 | 0.84 | HPRT1 (0.55) | HPRT1MEN1ALDH1A1LMNACYP3A4 | |
| Ammonia Solution, Strong SCHEMBL10901621 | 0.83 | HPRT1 (0.54) | HPRT1MEN1ALDH1A1LMNACYP3A4 | |
| Water SCHEMBL10601101 | 0.83 | HPRT1 (0.54) | HPRT1MEN1ALDH1A1LMNACYP3A4 | |
| SCHEMBL28646181 | 0.83 | HPRT1 (0.75) | HPRT1MEN1ALDH1A1LMNACYP3A4 | |
| SCHEMBL8896070 | 0.83 | HPRT1 (0.74) | HPRT1MEN1ALDH1A1LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7205404-B1 | Phosphorus-containing prodrugs | METABASIS THERAPEUTICS, INC. (US) | 2007-04-17 | — | — | US | claimed |
| US-6878728-B1 | Inhibitors of aspartyl protease | VERTEX PHARMACEUTICAL INCORPORATED (US) | 2005-04-12 | — | — | US | claimed |
| US-6663858-B1 | In Vivo gene transfer using implanted retroviral producer cells | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-12-16 | — | — | US | claimed |
| US-6663857-B1 | In vivo gene transfer using implanted retroviral producer cells | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-12-16 | — | — | US | claimed |
| EP-1143935-A3 | CONTROLLED-RELEASE BIOCOMPATIBLE OCULAR DRUG DELIVERY IMPLANT DEVICES AND METHODS | Oculex Pharmaceuticals, Inc. (US) | 2002-09-18 | — | — | EP | claimed |
| US-6331313-B1 | DRUG CORE COVERED BY IMPERMEABLE POLYMERIC OUTER LAYER WHICH HAS ONE OR MORE ORIFICES THROUGH WHICH OCULAR FLUIDS MAY PASS TO CONTACT THE CORE AND DISSOLVE DRUG | OCULEX PHARMACETICALS, INC. | 2001-12-18 | — | — | US | claimed |
| EP-1143935-A2 | CONTROLLED-RELEASE BIOCOMPATIBLE OCULAR DRUG DELIVERY IMPLANT DEVICES AND METHODS | Oculex Pharmaceuticals, Inc. (US) | 2001-10-17 | — | — | EP | claimed |
| WO-2001030323-A2 | CONTROLLED-RELEASE BIOCOMPATIBLE OCULAR DRUG DELIVERY IMPLANT DEVICES AND METHODS | OCULEX PHARMACEUTICALS, INC. (US) | 2001-05-03 | — | — | WO | claimed |
| EP-0594223-B1 | Combination of therapeutic nucleosides and further therapeutic agents. | WELLCOME FOUND (GB) | 2000-03-01 | — | — | EP | claimed |
| US-5529774-A | In vivo transfer of the HSV-TK gene implanted retroviral producer cells | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-06-25 | — | — | US | claimed |
| EP-0291633-B1 | USE OF 3'-AZIDO-3'-DEOXYTHYMIDINE IN THE TREATMENT OR PROPHYLAXIS OF HUMAN RETROVIRAL INFECTIONS | THE WELLCOME FOUNDATION LIMITED (GB) | 1992-11-04 | — | — | EP | claimed |
| US-4902678-A | SYNERGISTIC MIXTURE; HERPES VIRUS INFECTIONS | SYNTEX (U.S.A.) INC. (US) | 1990-02-20 | — | — | US | claimed |
| EP-0119757-B1 | GUANINE DERIVATIVES, COMPOSITIONS CONTAINING THEM, AND THEIR ANTI-VIRAL USE | SYNTEX (U.S.A.) INC. (US) | 1988-08-10 | — | — | EP | claimed |
| EP-0217580-A2 | Therapeutic nucleosides | THE WELLCOME FOUNDATION LIMITED (GB) | 1987-04-08 | — | — | EP | claimed |
| EP-0109234-B1 | COMPOSITIONS COMPRISING INTERFERON AND THEIR THERAPEUTIC USE | SYNTEX (U.S.A.) INC. (US) | 1987-04-01 | — | — | EP | claimed |
| EP-0101441-B1 | ANTI-VIRAL COMPOSITIONS | SYNTEX (U.S.A.) INC. (US) | 1987-01-14 | — | — | EP | claimed |
| EP-0135713-A2 | Antiviral combinations | THE WELLCOME FOUNDATION LIMITED (GB) | 1985-04-03 | — | — | EP | claimed |
| EP-0119757-A2 | Guanine derivatives, compositions containing them, and their anti-viral use | SYNTEX (U.S.A.) INC. (US) | 1984-09-26 | — | — | EP | claimed |
| US-4462986-A | INTERFERON AND 9-((2-HYDROXY-1-(HYDROXYMETHYL)-ETHOXY)METHYL)GUANINE | ENS BIO LOGICALS, INC. (CA) | 1984-07-31 | — | — | US | claimed |
| EP-0109234-A1 | Compositions comprising interferon and their therapeutic use | SYNTEX (U.S.A.) INC. (US) | 1984-05-23 | — | — | EP | claimed |